Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Outcomes following complete response to immune checkpoint inhibitors in endometrial cancer.
Journal: Gynecologic oncology
Published: May 29, 2026
Response to mirvetuximab soravtansine and weekly paclitaxel based on treatment sequencing in platinum-resistant ovarian cancer: Does order matter?
Journal: Gynecologic oncology
Published: April 14, 2026
Beyond extrapolation: Immunotherapy outcomes in recurrent vulvovaginal carcinoma.
Journal: Gynecologic oncology
Published: April 07, 2026
No time to waste: Evaluation of diagnostic delays in vulvar cancer.
Journal: Gynecologic oncology
Published: April 05, 2026
Dapsone-induced methemoglobinemia in gynecologic cancer patients treated with immune checkpoint Inhibitors: a case series.
Journal: Gynecologic oncology reports
Published: December 17, 2025
Patient perspectives of telemedicine in gynecologic oncology during COVID.
Journal: Gynecologic oncology reports
Published: July 12, 2022
Association of Physician Densities and Gynecologic Cancer Outcomes in the United States.
Journal: Obstetrics and gynecology
Published: April 24, 2022
Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study.
Journal: JCO precision oncology
Published: January 07, 2022
Dermatofibrosarcoma protuberans: A rare and devastating tumor of the vulva.
Journal: Gynecologic oncology reports
Published: November 19, 2018
Functional characterization of recurrent FOXA2 mutations seen in endometrial cancers.
Journal: International journal of cancer
Published: March 14, 2018
Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of Medicine.
Journal: Gynecologic oncology
Published: February 06, 2017
Last Updated: 09/26/2026